Vimarsana
Biggest News Aggregation in the World

Page 13 - Cell Line News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cell Line. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cell Line Today - Breaking & Trending Today

Study shows SARS-CoV-2 causes DNA damage and elicits an altered DNA damage response - Vimarsana News

Study shows SARS-CoV-2 causes DNA damage and elicits an altered DNA damage response

Researchers assessed the association between SARS-CoV-2 infection and DNA damage and cellular senescence.

ProBioGen's Growth Strategy Continues Successfully - Vimarsana News

ProBioGen's Growth Strategy Continues Successfully

Julian Collins, Jana Windt and Michiel Stork Join Biopharma Company’s Leadership TeamBERLIN, Germany, March 02, 2023 / B3C newswire / -- ProBioGen has seen significant growth with over 300 employees now working across its three locations in Berlin. In line with this growth, three crucial positions have been filled....

Beckman Coulter Life Sciences Presenting at SLAS2023 - Vimarsana News

Beckman Coulter Life Sciences Presenting at SLAS2023

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, will have a full team of dedicated professionals and informative programming at the upcoming Society for Laboratory Automation and Screening (SLAS) International Conference and Exhibition.

Global Cell Line Development Market Outlook 2022-2031: Increasing Demand for Monoclonal Antibodies Fuels Growth - Vimarsana News

Global Cell Line Development Market Outlook 2022-2031: Increasing Demand for Monoclonal Antibodies Fuels Growth

/PRNewswire/ -- The "Global Cell Line Development Market Outlook 2031" report has been added to ResearchAndMarkets.com's offering. The global cell line...

Researchers develop a cell line to address the challenges facing cellular modeling of disease - Vimarsana News

Researchers develop a cell line to address the challenges facing cellular modeling of disease

Bill Skarnes and team established and characterized a stable iPSC line, KOLF2.1J, to act as a high-quality baseline platform for modeling human disease.